Engineered Plasmonic and Fluorescent Nanomaterials for Biosensing, Motion, Imaging, and Therapeutic Applications
Source abstract
Abstract
Abstract The field of nanophotonics has seen remarkable advances, with gold‐based materials standing out. By precisely fine‐tuning the size and shape of metal nanoparticles (NPs), such as gold nanoparticles (AuNPs), it has been possible to gain control over light interaction, modulating localized surface plasmon resonance (LSPR), a phenomenon that involves the collective oscillation of free conduction electrons. This has opened the path toward more powerful biomedical applications, including surface‐enhanced Raman spectroscopy (SERS) and photothermal therapy (PTT). When AuNPs dimensions fall below 2 nm, they become gold nanoclusters (AuNCs), losing the LSPR but acquitting fluorescence due to their molecule‐like behavior. This unique feature makes them ideal for high‐resolution imaging, biomarker detection, and advanced therapies. Beyond traditional uses, the recent inclusion of AuNPs into nanomotors (NMs) enhances precise in vivo tracking and targeted drug delivery. This review highlights the different applications of plasmonic nanomaterials with particular emphasis on AuNPs and AuNCs as a function of their shapes, sizes, and stabilization ligands. Moreover, it dives into the biosensing applications of plasmonic materials by addressing their so‐called far‐field and near‐field optical properties, giving a detailed overview of different high‐sensitivity immunoassays and biosensing. A comprehensive outlook on the evolution of plasmonic‐based materials for the next therapies is provided.
Source: crossref · Quality: baseline
Research context
OpenAlex topics: Nanocluster Synthesis and Applications · Gold and Silver Nanoparticles Synthesis and Applications · Advanced Nanomaterials in Catalysis
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
Affiliations
Institute for Bioengineering of Catalonia (IBEC) Barcelona Institute of Science and Technology (BIST) Baldiri i Reixac 10‐12 Barcelona 08028 Spain
Nanobots Therapeutics SL Baldiri i Reixac 4 08028 Barcelona Spain
Institució Catalana de Recerca i Estudies Avancats (ICREA) Passeig Lluís Companys 23 Barcelona 08010 Spain
Funding
European Research Council · HORIZON EUROPE European Innovation Council · H2020 European Research Council · Ministerio de Ciencia e Innovación · Fundación BBVA
References (100+)
Show source-provided references
1. 10.1039/b708342d10.1039/b708342d ↗
2. 10.1016/j.mattod.2015.07.00410.1016/j.mattod.2015.07.004 ↗
3. 10.1162/posc.2006.14.1.9710.1162/posc.2006.14.1.97 ↗
4. 10.3390/ma1002009710.3390/ma10020097 ↗
5. 10.3390/nano1418152710.3390/nano14181527 ↗
6. 10.1016/B978-0-323-41736-5.00005-410.1016/B978-0-323-41736-5.00005-4 ↗
7. 10.1088/1361-648X/aa60f310.1088/1361-648X/aa60f3 ↗
8. 10.1016/j.talanta.2018.02.08810.1016/j.talanta.2018.02.088 ↗
9. 10.1021/acsami.6b0254810.1021/acsami.6b02548 ↗
10. 10.1021/ja048726910.1021/ja0487269 ↗
11. 10.1038/s41565-023-01577-y10.1038/s41565-023-01577-y ↗
12. 10.1002/wnan.144910.1002/wnan.1449 ↗
13. 10.1070/QE2012v042n12ABEH01493210.1070/QE2012v042n12ABEH014932 ↗
14. 10.3390/molecules2907157410.3390/molecules29071574 ↗
15. 10.1021/ar200331z10.1021/ar200331z ↗
16. 10.1117/1.JNP.6.06450410.1117/1.JNP.6.064504 ↗
17. 10.1557/mrs2005.9610.1557/mrs2005.96 ↗
18. 10.3390/pharmaceutics1610133210.3390/pharmaceutics16101332 ↗
19. 10.1021/jp061667w10.1021/jp061667w ↗
20. 10.3390/ma1106088210.3390/ma11060882 ↗
21. 10.1088/0957-4484/23/7/07510210.1088/0957-4484/23/7/075102 ↗
22. 10.1016/j.talanta.2024.12718410.1016/j.talanta.2024.127184 ↗
23. 10.1016/j.snb.2024.13698610.1016/j.snb.2024.136986 ↗
24. 10.1016/j.jece.2024.11509410.1016/j.jece.2024.115094 ↗
25. 10.1021/acssensors.4c0121010.1021/acssensors.4c01210 ↗
26. 10.3390/bios1501001610.3390/bios15010016 ↗
27. 10.1021/jacs.4c1668610.1021/jacs.4c16686 ↗
28. 10.1002/ppsc.20240018510.1002/ppsc.202400185 ↗
29. 10.1039/D4TC04578E10.1039/D4TC04578E ↗
30. 10.1021/acs.chemmater.1c0322310.1021/acs.chemmater.1c03223 ↗
31. 10.1021/acs.chemmater.6b0334910.1021/acs.chemmater.6b03349 ↗
32. 10.1016/j.snb.2017.05.14910.1016/j.snb.2017.05.149 ↗
33. 10.1021/nn901064m10.1021/nn901064m ↗
34. 10.1016/j.bios.2011.06.01110.1016/j.bios.2011.06.011 ↗
35. 10.1039/D0NA00472C10.1039/D0NA00472C ↗
36. 10.1021/acs.chemrev.8b0034110.1021/acs.chemrev.8b00341 ↗
37. 10.1021/acs.accounts.7b0016510.1021/acs.accounts.7b00165 ↗
38. 10.1002/smll.20240409710.1002/smll.202404097 ↗
39. 10.1088/1468-6996/16/3/03461010.1088/1468-6996/16/3/034610 ↗
40. 10.1021/acs.chemmater.4c0251310.1021/acs.chemmater.4c02513 ↗
41. 10.1016/j.apsusc.2014.09.17310.1016/j.apsusc.2014.09.173 ↗
42. 10.1038/s41557-024-01574-110.1038/s41557-024-01574-1 ↗
43. 10.1016/j.msec.2020.11127010.1016/j.msec.2020.111270 ↗
44. 10.1021/acsnano.3c0800510.1021/acsnano.3c08005 ↗
45. 10.1021/ja902062j10.1021/ja902062j ↗
46. 10.1021/jacs.4c0686810.1021/jacs.4c06868 ↗
47. 10.1002/adma.20211021910.1002/adma.202110219 ↗
48. 10.1002/adfm.20200156610.1002/adfm.202001566 ↗
49. 10.1021/acsami.6b1640810.1021/acsami.6b16408 ↗
50. 10.1002/adma.20160489410.1002/adma.201604894 ↗
51. 10.3390/pharmaceutics1702017610.3390/pharmaceutics17020176 ↗
52. 10.1002/cplu.20240078310.1002/cplu.202400783 ↗
53. 10.7150/thno.1065710.7150/thno.10657 ↗
54. 10.4155/tde-2017-004910.4155/tde-2017-0049 ↗
55. 10.1021/nl504444w10.1021/nl504444w ↗
56. 10.1021/acsami.8b0132010.1021/acsami.8b01320 ↗
57. 10.1021/acsnano.9b0926410.1021/acsnano.9b09264 ↗
58. 10.1007/s12010-024-05091-210.1007/s12010-024-05091-2 ↗
59. 10.1038/s41467-025-58636-210.1038/s41467-025-58636-2 ↗
60. 10.1038/s41467-021-26694-x10.1038/s41467-021-26694-x ↗
61. 10.1126/sciadv.adw703210.1126/sciadv.adw7032 ↗
62. 10.1021/acsnano.4c1272610.1021/acsnano.4c12726 ↗
63. 10.1002/smll.20230938710.1002/smll.202309387 ↗
64. 10.1021/acsnano.2c0938010.1021/acsnano.2c09380 ↗
65. 10.1021/acsnano.4c0176010.1021/acsnano.4c01760 ↗
66. 10.1021/nn502360t10.1021/nn502360t ↗
67. 10.1126/sciadv.abm512610.1126/sciadv.abm5126 ↗
68. 10.1021/acsami.0c0234210.1021/acsami.0c02342 ↗
69. 10.1126/scirobotics.abd282310.1126/scirobotics.abd2823 ↗
70. 10.1021/acsnano.0c1065810.1021/acsnano.0c10658 ↗
71. 10.1021/acsphotonics.8b0003410.1021/acsphotonics.8b00034 ↗
72. 10.1039/D3NR02739B10.1039/D3NR02739B ↗
73. 10.1002/smll.20230620810.1002/smll.202306208 ↗
74. 10.1038/s41467-024-49217-w10.1038/s41467-024-49217-w ↗
75. 10.1038/s41467-021-22279-w10.1038/s41467-021-22279-w ↗
76. 10.1021/acs.chemmater.3c0114010.1021/acs.chemmater.3c01140 ↗
77. 10.1038/s41467-022-28212-z10.1038/s41467-022-28212-z ↗
78. 10.1002/macp.20230006010.1002/macp.202300060 ↗
79. 10.1016/B978-0-323-41736-5.00005-410.1016/B978-0-323-41736-5.00005-4 ↗
80. 10.1021/ar800035u10.1021/ar800035u ↗
81. 10.1038/nmat216210.1038/nmat2162 ↗
82. 10.1038/nbt110010.1038/nbt1100 ↗
83. 10.1016/j.nantod.2009.04.00110.1016/j.nantod.2009.04.001 ↗
84. 10.1039/c1nr10788g10.1039/c1nr10788g ↗
85. 10.1021/jp026731y10.1021/jp026731y ↗
86. 10.1002/978352761815610.1002/9783527618156 ↗
87. 10.1039/C6RA16750K10.1039/C6RA16750K ↗
88. 10.1039/C5CC01286D10.1039/C5CC01286D ↗
89. 10.1016/j.bios.2015.02.02610.1016/j.bios.2015.02.026 ↗
90. 10.1038/nnano.2012.18610.1038/nnano.2012.186 ↗
91. 10.1039/C6NR06079J10.1039/C6NR06079J ↗
92. 10.1039/C6NR04897H10.1039/C6NR04897H ↗
93. 10.1039/C3AN01835K10.1039/C3AN01835K ↗
94. 10.1021/acsomega.7b0184010.1021/acsomega.7b01840 ↗
95. 10.1016/j.bios.2017.05.02010.1016/j.bios.2017.05.020 ↗
96. 10.1016/j.aca.2016.04.05910.1016/j.aca.2016.04.059 ↗
97. 10.1016/j.talanta.2015.04.00910.1016/j.talanta.2015.04.009 ↗
98. 10.1021/acs.analchem.1c0385010.1021/acs.analchem.1c03850 ↗
99. 10.1016/j.cca.2009.01.01510.1016/j.cca.2009.01.015 ↗
100. 10.1021/jp205158w10.1021/jp205158w ↗